Oryzon Genomics S.A. (ORYZF)
OTCMKTS · Delayed Price · Currency is USD
3.030
0.00 (0.00%)
At close: May 7, 2025

Oryzon Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
23594127142162257
Upgrade
Market Cap Growth
97.84%-26.17%-10.67%-12.21%-36.97%81.12%
Upgrade
Enterprise Value
247102134137141220
Upgrade
Last Close Price
3.031.621.702.604.003.60
Upgrade
PS Ratio
29.5512.318.108.4813.4222.07
Upgrade
PB Ratio
-1.041.411.832.002.77
Upgrade
P/TBV Ratio
-1.041.411.852.022.78
Upgrade
EV/Sales Ratio
29.6213.408.538.1911.6618.92
Upgrade
Debt / Equity Ratio
-0.190.220.310.250.18
Upgrade
Asset Turnover
-0.070.140.160.110.11
Upgrade
Inventory Turnover
-67.1130.808.173.551.74
Upgrade
Quick Ratio
-0.740.871.343.755.47
Upgrade
Current Ratio
-0.750.871.343.765.51
Upgrade
Return on Equity (ROE)
--4.34%-4.35%-5.88%-6.37%-4.96%
Upgrade
Return on Assets (ROA)
--2.61%-2.71%-3.45%-4.63%-3.08%
Upgrade
Return on Capital (ROIC)
--2.77%-2.92%-3.74%-4.92%-3.27%
Upgrade
Earnings Yield
-1.94%-4.05%-2.92%-3.18%-3.29%-1.62%
Upgrade
FCF Yield
--6.28%-0.50%-1.44%-2.67%-2.37%
Upgrade
Buyback Yield / Dilution
-5.77%-6.35%-10.10%-4.80%--15.99%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.